Vera Therapeutics (VERA) Restructuring Costs (2020 - 2021)
Vera Therapeutics (VERA) reported Restructuring Costs of -$116000.0 for Q4 2021, down 107.34% on a YoY basis from $1.6 million in Q4 2020, and down 474.19% quarter-over-quarter from $31000.0 in Q3 2021.
Vera Therapeutics (VERA) Restructuring Costs (2020 - 2021) Analysis & Trends
Vera Therapeutics has reported Restructuring Costs for 2 years, with the latest figure at -$116000.0 in Q4 2021.
- For the quarter ending Q4 2021, Restructuring Costs fell 107.34% year-over-year to -$116000.0; the trailing twelve-month figure through Dec 2021 stood at $2.9 million (changed N/A YoY), and the FY2020 full-year result was $3.0 million, changed N/A from the prior year.
- Restructuring Costs for Q4 2021 stood at -$116000.0, down from $31000.0 in the prior quarter.
- The five-year high for Restructuring Costs was $1.6 million in Q4 2020, with the low at -$116000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vera Therapeutics | 2.51 Bn | 1.91 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -116,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Dec 31, 2020 | 1.58 Mn |
| Sep 30, 2020 | 1.42 Mn |